
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $454.2M | $583.3M | $646.1M | $666.4M | $717.3M | |
Revenue Growth (YoY) | 8.3% | 28.43% | 10.78% | 3.14% | 7.63% | |
Cost of Revenues | $259.9M | $341M | $383M | $381.4M | $413.3M | |
Gross Profit | $194.3M | $242.3M | $263.1M | $285.1M | $304M | |
Gross Profit Margin | 42.78% | 41.54% | 40.73% | 42.77% | 42.38% | |
R&D Expenses | $79M | $88.7M | $103.6M | $112.9M | $124.5M | |
Selling, General & Admin | $76.3M | $84.5M | $89M | $92.8M | $99.7M | |
Other Inc / (Exp) | -$9.2M | -$5M | -- | -$97.1M | -$28.1M | |
Operating Expenses | $170.4M | $185.6M | $202.9M | $215.1M | $208.9M | |
Operating Income | $23.9M | $56.7M | $60.3M | $69.9M | $95.1M | |
Net Interest Expenses | $23.2M | $26M | $9.3M | $1.2M | -- | |
EBT. Incl. Unusual Items | -$8.5M | $25.7M | $51M | -$28.3M | $68.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$73K | -$358K | -$116M | $2M | -$4.9M | |
Net Income to Company | -$8.4M | $26M | $166.9M | -$30.4M | $73.7M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$8.4M | $26M | $166.9M | -$30.4M | $73.7M | |
Basic EPS (Cont. Ops) | -$0.17 | $0.53 | $3.35 | -$0.56 | $1.31 | |
Diluted EPS (Cont. Ops) | -$0.17 | $0.49 | $2.71 | -$0.56 | $1.23 | |
Weighted Average Basic Share | $48.4M | $49.1M | $49.9M | $53.8M | $56.4M | |
Weighted Average Diluted Share | $48.4M | $53.6M | $65.6M | $53.8M | $61.6M | |
EBITDA | $47M | $80.1M | $88.1M | $8.4M | $105M | |
EBIT | $16.3M | $54M | $62.5M | -$16.6M | $79.9M | |
Revenue (Reported) | $454.2M | $583.3M | $646.1M | $666.4M | $717.3M | |
Operating Income (Reported) | $23.9M | $56.7M | $60.3M | $69.9M | $95.1M | |
Operating Income (Adjusted) | $16.3M | $54M | $62.5M | -$16.6M | $79.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $133.7M | $156.4M | $153.5M | $174.5M | $167.3M | |
Revenue Growth (YoY) | 27.95% | 16.99% | -1.87% | 13.67% | -4.12% | |
Cost of Revenues | $78.8M | $90.4M | $91.5M | $99.1M | $98.8M | |
Gross Profit | $54.9M | $66M | $62M | $75.4M | $68.5M | |
Gross Profit Margin | 41.07% | 42.2% | 40.4% | 43.22% | 40.93% | |
R&D Expenses | $21.8M | $24.1M | $27.6M | $29.6M | $28.5M | |
Selling, General & Admin | $20.3M | $22.9M | $22.6M | $24.7M | $25M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $45.5M | $49.5M | $52.2M | $53.4M | $54.3M | |
Operating Income | $9.4M | $16.5M | $9.8M | $22M | $14.1M | |
Net Interest Expenses | $6.6M | $2.8M | $802K | -- | -- | |
EBT. Incl. Unusual Items | $2.8M | $13.7M | $9M | $22.8M | $15M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $298K | $384K | $263K | $896K | $3M | |
Net Income to Company | $2.5M | $13.3M | $8.7M | $21.9M | $11.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $2.5M | $13.3M | $8.7M | $21.9M | $11.9M | |
Basic EPS (Cont. Ops) | $0.05 | $0.27 | $0.17 | $0.39 | $0.21 | |
Diluted EPS (Cont. Ops) | $0.05 | $0.24 | $0.17 | $0.37 | $0.20 | |
Weighted Average Basic Share | $48.6M | $49.6M | $50.6M | $56M | $57.8M | |
Weighted Average Diluted Share | $53.1M | $65.3M | $59.9M | $60.8M | $60.2M | |
EBITDA | $16.4M | $22.8M | $18.2M | $31.8M | $22.5M | |
EBIT | $9.6M | $16.6M | $11.9M | $25.4M | $17.5M | |
Revenue (Reported) | $133.7M | $156.4M | $153.5M | $174.5M | $167.3M | |
Operating Income (Reported) | $9.4M | $16.5M | $9.8M | $22M | $14.1M | |
Operating Income (Adjusted) | $9.6M | $16.6M | $11.9M | $25.4M | $17.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $483.4M | $606M | $643.2M | $687.4M | $710.1M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $280.6M | $352.6M | $384.1M | $389M | $413.1M | |
Gross Profit | $202.8M | $253.4M | $259.2M | $298.5M | $297.1M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $81.6M | $91M | $107M | $114.9M | $123.4M | |
Selling, General & Admin | $78.2M | $87.2M | $88.7M | $94.8M | $100M | |
Other Inc / (Exp) | -$8.6M | -- | -- | -$97.1M | -- | |
Operating Expenses | $174.6M | $189.6M | $205.6M | $216.3M | $209.8M | |
Operating Income | $28.2M | $63.8M | $53.6M | $82.2M | $87.2M | |
Net Interest Expenses | $24.9M | $22.2M | $7.3M | -- | -- | |
EBT. Incl. Unusual Items | -$5.4M | $36.6M | $46.3M | -$14.6M | $61.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$43K | -$273K | -$116.1M | $2.7M | -$2.7M | |
Net Income to Company | -$5.3M | $36.9M | $162.4M | -$17.3M | $63.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$5.3M | $36.9M | $162.4M | -$17.3M | $63.8M | |
Basic EPS (Cont. Ops) | -$0.11 | $0.75 | $3.24 | -$0.39 | $1.13 | |
Diluted EPS (Cont. Ops) | -$0.11 | $0.68 | $2.62 | -$0.45 | $1.07 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $50.3M | $86.6M | $83.4M | $22M | $95.8M | |
EBIT | $20.5M | $61.1M | $57.8M | -$3.1M | $72M | |
Revenue (Reported) | $483.4M | $606M | $643.2M | $687.4M | $710.1M | |
Operating Income (Reported) | $28.2M | $63.8M | $53.6M | $82.2M | $87.2M | |
Operating Income (Adjusted) | $20.5M | $61.1M | $57.8M | -$3.1M | $72M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $133.7M | $156.4M | $153.5M | $174.5M | $167.3M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $78.8M | $90.4M | $91.5M | $99.1M | $98.8M | |
Gross Profit | $54.9M | $66M | $62M | $75.4M | $68.5M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $21.8M | $24.1M | $27.6M | $29.6M | $28.5M | |
Selling, General & Admin | $20.3M | $22.9M | $22.6M | $24.7M | $25M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $45.5M | $49.5M | $52.2M | $53.4M | $54.3M | |
Operating Income | $9.4M | $16.5M | $9.8M | $22M | $14.1M | |
Net Interest Expenses | $6.6M | $2.8M | $802K | -- | -- | |
EBT. Incl. Unusual Items | $2.8M | $13.7M | $9M | $22.8M | $15M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $298K | $384K | $263K | $896K | $3M | |
Net Income to Company | $2.5M | $13.3M | $8.7M | $21.9M | $11.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $2.5M | $13.3M | $8.7M | $21.9M | $11.9M | |
Basic EPS (Cont. Ops) | $0.05 | $0.27 | $0.17 | $0.39 | $0.21 | |
Diluted EPS (Cont. Ops) | $0.05 | $0.24 | $0.17 | $0.37 | $0.20 | |
Weighted Average Basic Share | $48.6M | $49.6M | $50.6M | $56M | $57.8M | |
Weighted Average Diluted Share | $53.1M | $65.3M | $59.9M | $60.8M | $60.2M | |
EBITDA | $16.4M | $22.8M | $18.2M | $31.8M | $22.5M | |
EBIT | $9.6M | $16.6M | $11.9M | $25.4M | $17.5M | |
Revenue (Reported) | $133.7M | $156.4M | $153.5M | $174.5M | $167.3M | |
Operating Income (Reported) | $9.4M | $16.5M | $9.8M | $22M | $14.1M | |
Operating Income (Adjusted) | $9.6M | $16.6M | $11.9M | $25.4M | $17.5M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $129.6M | $119.7M | $154.9M | $158.8M | $145.6M | |
Short Term Investments | $189.8M | $104.2M | $147.5M | $146.7M | $198.7M | |
Accounts Receivable, Net | $80M | $109.6M | $124.2M | $103M | $96.8M | |
Inventory | $145.9M | $170.9M | $206.9M | $237.6M | $246.7M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $19.3M | $26M | $18.3M | $35.5M | $39.3M | |
Total Current Assets | $586.9M | $549.4M | $668.9M | $706.3M | $764.5M | |
Property Plant And Equipment | $75.5M | $128.6M | $133.7M | $142.8M | $140.3M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $181.9M | $181.9M | $181.9M | $215M | $215M | |
Other Intangibles | $46.2M | $33.9M | $23.9M | $43.9M | $8.8M | |
Other Long-Term Assets | $6M | $3.5M | $3.4M | $3.1M | $2.8M | |
Total Assets | $898.1M | $899M | $1.1B | $1.2B | $1.3B | |
Accounts Payable | $33.7M | $44.5M | $52M | $42.4M | $43.5M | |
Accrued Expenses | $35.4M | $62.8M | $43.6M | $40.2M | $43.3M | |
Current Portion Of Long-Term Debt | -- | -- | $20.2M | -- | $26.5M | |
Current Portion Of Capital Lease Obligations | $4.1M | $4.4M | $3.3M | $4M | $3.8M | |
Other Current Liabilities | $2.7M | $7.6M | $7.1M | $11.6M | $6.6M | |
Total Current Liabilities | $146.7M | $189.2M | $257.9M | $218M | $192.3M | |
Long-Term Debt | $321.1M | $229.4M | $254.5M | $274.9M | $249.7M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $489.7M | $461.3M | $550.4M | $556.6M | $480.8M | |
Common Stock | $497K | $507K | $517K | $564K | $569K | |
Other Common Equity Adj | $1.8M | $1.5M | $928K | $1.6M | $1.5M | |
Common Equity | $408.4M | $437.6M | $577.8M | $672.4M | $770.8M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $408.4M | $437.6M | $577.8M | $672.4M | $770.8M | |
Total Liabilities and Equity | $898.1M | $899M | $1.1B | $1.2B | $1.3B | |
Cash and Short Terms | $319.4M | $223.9M | $302.4M | $305.4M | $344.3M | |
Total Debt | $321.1M | $229.4M | $274.7M | $274.9M | $276.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $140.7M | $127.6M | $140.7M | $174M | $174.9M | |
Short Term Investments | $186.1M | $103.3M | $112.2M | $122.9M | $178.4M | |
Accounts Receivable, Net | $87.5M | $99.5M | $120.1M | $106.5M | $114.4M | |
Inventory | $156.2M | $179.1M | $225.7M | $243.3M | $254.1M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $25.8M | $34.2M | $26.4M | $34.6M | $39.3M | |
Total Current Assets | $618.2M | $570M | $643.3M | $715.9M | $794.8M | |
Property Plant And Equipment | $94.8M | $131.9M | $139.5M | $139M | $139.8M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $181.9M | $181.9M | $215M | $215M | $215M | |
Other Intangibles | $42.8M | $31.4M | $50.3M | $42.1M | $8M | |
Other Long-Term Assets | $6.1M | $3.5M | $3.2M | $3.1M | $2.7M | |
Total Assets | $945.2M | $920.4M | $1.2B | $1.2B | $1.3B | |
Accounts Payable | $42.6M | $56.2M | $62M | $54M | $57.8M | |
Accrued Expenses | $40M | $63.7M | $44.7M | $48.8M | $46.5M | |
Current Portion Of Long-Term Debt | -- | $20.1M | -- | $26.4M | -- | |
Current Portion Of Capital Lease Obligations | $4.4M | $4.4M | $3.5M | $4M | $3.8M | |
Other Current Liabilities | $3.5M | $8.9M | $19.2M | $3.3M | $8.6M | |
Total Current Liabilities | $163.7M | $220.7M | $267.2M | $234.4M | $178.9M | |
Long-Term Debt | $324.6M | $253.8M | $254.7M | $248.8M | $250M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $532.8M | $516.8M | $581.7M | $545.8M | $467M | |
Common Stock | $502K | $513K | $517K | $566K | $583K | |
Other Common Equity Adj | $1.8M | $661K | $1.4M | $1.5M | $1.6M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $412.5M | $403.6M | $585.6M | $687.9M | $811.9M | |
Total Liabilities and Equity | $945.2M | $920.4M | $1.2B | $1.2B | $1.3B | |
Cash and Short Terms | $326.9M | $230.9M | $252.9M | $296.9M | $353.3M | |
Total Debt | $324.6M | $273.9M | $254.7M | $275.2M | $250M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$8.4M | $26M | $166.9M | -$30.4M | $73.7M | |
Depreciation & Amoritzation | $30.7M | $26.1M | $25.6M | $25M | $25.1M | |
Stock-Based Compensation | $12.7M | $15.2M | $23M | $28.6M | $35.9M | |
Change in Accounts Receivable | -$30.4M | -$26.7M | -$12.8M | $13.3M | -$6.6M | |
Change in Inventories | -$11.5M | -$24.8M | -$37.3M | -$35.2M | -$8.3M | |
Cash From Operations | $43M | $67.7M | $108.5M | $61.7M | $63.8M | |
Capital Expenditures | $6.8M | $40.6M | $24.6M | $27.9M | $18.1M | |
Cash Acquisitions | -- | -- | -- | -$30.4M | -- | |
Cash From Investing | -$71.8M | $44.5M | -$68.9M | -$53.3M | -$64.5M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $120.1M | -- | -- | $223.2M | -- | |
Long-Term Debt Repaid | -$81.2M | -$115.6M | -- | -$219M | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$12.6M | -$9.8M | -$8.2M | -$13.5M | -$17.9M | |
Cash From Financing | $29.1M | -$122M | -$4.6M | -$4.7M | -$12.6M | |
Beginning Cash (CF) | $130M | $130.3M | $120.5M | $155.5M | $159.1M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $327K | -$9.8M | $35.1M | $3.7M | -$13.3M | |
Ending Cash (CF) | $130.3M | $120.5M | $155.5M | $159.1M | $145.8M | |
Levered Free Cash Flow | $36.2M | $27.1M | $83.9M | $33.7M | $45.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $2.5M | $13.3M | $8.7M | $21.9M | $11.9M | |
Depreciation & Amoritzation | $6.8M | $6.2M | $6.3M | $6.4M | $5M | |
Stock-Based Compensation | $3.2M | $4.5M | $7M | $8.1M | $9.2M | |
Change in Accounts Receivable | -$6.8M | $2.8M | $3.2M | -$13.5M | -$14M | |
Change in Inventories | -$10.5M | -$8.3M | -$25.8M | -$4.8M | -$7.3M | |
Cash From Operations | $10.5M | $24.8M | $13.9M | $9.4M | $20M | |
Capital Expenditures | $2M | $10.9M | $6.9M | $6M | $6.8M | |
Cash Acquisitions | -- | -- | -$30.4M | -- | -- | |
Cash From Investing | $1.4M | -$11.2M | -$762K | $20.7M | $14.5M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -$20.2M | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$1.6M | -$6.8M | -$8.5M | -$16.2M | -$6.7M | |
Cash From Financing | -$747K | -$5.8M | -$27.4M | -$14.8M | -$5.3M | |
Beginning Cash (CF) | $130.3M | $120.5M | $155.5M | $159.1M | $145.8M | |
Foreign Exchange Rate Adjustment | -$30K | -$3K | $10K | -$42K | $9K | |
Additions / Reductions | $11.1M | $7.8M | -$14.3M | $15.2M | $29.2M | |
Ending Cash (CF) | $141.4M | $128.3M | $141.2M | $174.3M | $175.1M | |
Levered Free Cash Flow | $8.5M | $13.9M | $7M | $3.4M | $13.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$5.3M | $36.9M | $162.4M | -$17.3M | $63.8M | |
Depreciation & Amoritzation | $29.8M | $25.5M | $25.7M | $25.1M | $23.8M | |
Stock-Based Compensation | $12.3M | $16.5M | $25.5M | $29.6M | $37M | |
Change in Accounts Receivable | -$9.3M | -$17M | -$12.5M | -$3.4M | -$7.1M | |
Change in Inventories | -$24.4M | -$22.6M | -$54.8M | -$14.2M | -$10.8M | |
Cash From Operations | $55.9M | $82M | $97.6M | $57.1M | $74.4M | |
Capital Expenditures | $7.7M | $49.6M | $20.6M | $27M | $18.9M | |
Cash Acquisitions | -- | -- | -$30.4M | -- | -- | |
Cash From Investing | -$105.6M | $32M | -$58.5M | -$31.8M | -$70.7M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -$20.2M | -$198.8M | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$13.6M | -$15M | -$10M | -$21.2M | -$8.4M | |
Cash From Financing | $28.1M | -$127.1M | -$26.2M | $7.9M | -$3M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$21.6M | -$13M | $12.9M | $33.2M | $682K | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $48.2M | $32.4M | $77M | $30.1M | $55.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $2.5M | $13.3M | $8.7M | $21.9M | $11.9M | |
Depreciation & Amoritzation | $6.8M | $6.2M | $6.3M | $6.4M | $5M | |
Stock-Based Compensation | $3.2M | $4.5M | $7M | $8.1M | $9.2M | |
Change in Accounts Receivable | -$6.8M | $2.8M | $3.2M | -$13.5M | -$14M | |
Change in Inventories | -$10.5M | -$8.3M | -$25.8M | -$4.8M | -$7.3M | |
Cash From Operations | $10.5M | $24.8M | $13.9M | $9.4M | $20M | |
Capital Expenditures | $2M | $10.9M | $6.9M | $6M | $6.8M | |
Cash Acquisitions | -- | -- | -$30.4M | -- | -- | |
Cash From Investing | $1.4M | -$11.2M | -$762K | $20.7M | $14.5M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -$20.2M | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$1.6M | -$6.8M | -$8.5M | -$16.2M | -$6.7M | |
Cash From Financing | -$747K | -$5.8M | -$27.4M | -$14.8M | -$5.3M | |
Beginning Cash (CF) | $130.3M | $120.5M | $155.5M | $159.1M | $145.8M | |
Foreign Exchange Rate Adjustment | -$30K | -$3K | $10K | -$42K | $9K | |
Additions / Reductions | $11.1M | $7.8M | -$14.3M | $15.2M | $29.2M | |
Ending Cash (CF) | $141.4M | $128.3M | $141.2M | $174.3M | $175.1M | |
Levered Free Cash Flow | $8.5M | $13.9M | $7M | $3.4M | $13.2M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.